In addition, recent studies indicate that ovarian cancer cells upregulate anti-ferroptosis factors such as Solute Carrier Family 7 Member 11 (SLC7A11, also known as xCT), providing insights into its modulation and potential as a therapeutic target [14]. The gene discussed is SLC7A11; the disease is ovarian carcinoma.